While the cause of connective tissue diseases (CTDs) remains unknown the classification of individual patients will continue to depend on identifying certain patterns of clinical and laboratory features. This is the basis of the various classification criteria for systemic sclerosis,'l systemic lupus erythematosus (SLE),2 and other connective tissue diseases. As The prevalence of MCTD is not known precisely but it is generally considered to be more common than systemic sclerosis and polymyositis but less common than SLE. There is a marked female preponderance (about 8F: 1M) and apparently no ethnic group is particularly susceptible. Cases are recognised in children. It has been suggested that MCTD produces more morbidity in children with a higher prevalence of features such as significant myocarditis, glomerulonephritis, thrombocytopenia, seizures, and aseptic meningitis. These observations, however, may be the result of a selection bias.
The initial presentation is rarely distinctive and often comprises Raynaud's phenomenon, swollen puffy hands, polyarthritis, and rash. As the disease evolves, overlapping features tend to There are significant differences that seem to set eosinophilic fasciitis apart from systemic sclerosis, however. These include the relative absence of Raynaud's phenomenon, normal nailfold capillaries, sparing of the epidermis and dermis, infrequent visceral involvement, absence of the serological features which characterise systemic sclerosis, and the development of haematological complications, such as aplastic anaemia and thrombocytopenia, which are extremely rare in typical systemic sclerosis. 42 The cause is unknown. Multiple cases within a family with sharing of HLA genes has been reported, suggesting that genetic factors may be involved. 43 An interesting feature is the association of many cases with strenuous exertion, especially in men. There has been speculation that there is a hypersensitivity reaction to muscle tissue following exercise induced damage, but there may be multiple aetiological triggers. A temporal association has been reported with cancer,44 and the administration of drugs such as those used in antituberculous treatment45 and phenytoin.' Although exposure to toxic agents has been suggested in the pathogenesis of eosinophilic fasciitis, there is no evidence for this in most cases. Recently, there have been increasing reports, particularly from the USA, of L-tryptophan induced 'eosinophilia-myalgia syndrome', some cases ofwhich closely resemble eosinophilic fasciitis.47 48 Consumption of Ltryptophan has been implicated, which is sold over the counter for a variety ofneuropsychiatric disorders, insomnia, and various musculoskeletal complaints. Features of the syndrome include marked peripheral eosinophilia, intense myalgias, and sensory symptoms, which can progress to a severe neuromuscular disorder with axonal degeneration and myopathy, constitutional symptoms with fever and pulmonary manifestations, resembling Loffler's syndrome. About one third of patients develop oedema and cutaneous induration, mainly affecting the extremities, similar to eosinophilic fasciitis. 49 Interestingly, abnormal tryptophan metabolism has been postulated in both idiopathic scleroderma and eosinophilic fasciitis.5' Raised basal urine and plasma concentrations of kynurenine have been reported as well as higher concentrations after L-tryptophan loading. The possibility of a toxic contant of L-tryptophan in cases of eosinophilia-myalgia syndrome has not been excluded, however.
In contrast with systemic sclerosis, the female to male ratio in eosinophilic fasciitis is about equal. In a recent review of 52 patients seen at the Mayo Clinic5' the mean age of onset was 47 years (range 11-72) and in 24 (46%) it was related to strenuous exertion. A case has been reported to occur during pregnancy.52 Cutaneous manifestations are the presenting feature in most cases and evolve through three stages: pitting oedema, which is frequently present at onset, peau d'orange or dimpling, and induration. These stages are often present simultaneously in different areas of the body and virtually any part of the body can be involved, but the face is not usually affected. The arms and legs are most commonly affected (fig 2) and, in contrast with previously held views, simultaneous involvement of hands and feet is not uncommon. Not previously emphasised is the fact that localised morphoea may occur. Joint contractures, particularly of the elbows, ankles, and knees, are common, resulting from induration and sclerosis of subcutaneous tissue. Carpal tunnel syndrome is commonly described and occurs in about 25% of patients, sometimes preceding the skin manifestations.
Systemic involvement is more common than previously thought. Associated haematological disease is commonly reported. This includes aplastic anaemia, attributed in some cases to a serum inhibitor of erythroid stem cells, and thrombocytopenia associated in some cases with antibodies to platelets.55 Malignant transformation is also seen. 56 Blood eosinophilia, often impressive, is the most striking laboratory abnormality. Eosinophilia greater than 7% of the differential count occurs in over 60% of cases. Peripheral eosinophilia can be transient, however, even in the absence of corticosteroid treatment, and the diagnosis of eosinophilic fasciitis should not be dismissed because of a normal laboratory finding. Similarly, tissue eosinophilia seen on histological examination of the fascia correlates with the presence or absence of a peripheral eosinophilia. Antinuclear antibodies, which characterise systemic sclerosis, are not found in eosinophilic fasciitis.
A deep biopsy, which must include tissue from the epidermis to skeletal muscle including the deep fascia, confirms the diagnosis (fig 3) . Changes range from inflammation with minimal connective tissue change or connective tissue alteration to severe sclerosis. The deep fascia and septa of the subdermal fat are most extensively affected, whereas the epidermis is normal or only slightly atrophic. Some studies emphasise that there is overlap of histological features with systemic sclerosis.57 Tissue eosinophilia, for example, is also a feature of about 20% of patients with systemic sclerosis.
Initial reports suggest that eosinophilic fasciitis is a condition responsive to corticosteroids with a benign course. This, however, is not borne out in all cases described, and effects of therapeutic intervention must be judged against 
